General MedicationsORALStandard
VORICONAZOLE
VORICONAZOLE
Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview VORICONAZOLE is listed in Drugs@FDA under application 207371 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient VORICONAZOLE Form and strength TABLET;ORAL - 50MG Sponsor CHARTWELL RX Submission history Latest submission status date: 2024-09-25 00:00:00.
Structured Monograph
Clinical summary
Approval overview VORICONAZOLE is listed in Drugs@FDA under application 207371 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient VORICONAZOLE Form and strength TABLET;ORAL - 50MG Sponsor CHARTWELL RX Submission history Latest submission status date: 2024-09-25 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.